Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
5,000
-1,100
-18% -$343K ﹤0.01% 3401
2026
Q1
$1.78M Buy
6,100
+400
+7% +$129K ﹤0.01% 3006
2025
Q4
$1.62M Sell
5,700
-1,800
-24% -$511K ﹤0.01% 3214
2025
Q3
$2.23M Hold
7,500
﹤0.01% 2889
2025
Q2
$2.38M Buy
+7,500
New +$2.35M ﹤0.01% 2616
2025
Q1
Sell
-3,900
Closed -$1.35M 4500
2024
Q4
$1.35M Hold
3,900
﹤0.01% 3022
2024
Q3
$1.32M Buy
+3,900
New +$1.25M ﹤0.01% 3065
2022
Q2
Sell
-10,000
Closed -$1.94M 5547
2022
Q1
$1.94M Hold
10,000
﹤0.01% 3332
2021
Q4
$2.31M Hold
10,000
﹤0.01% 3223
2021
Q3
$2.04M Buy
+10,000
New +$1.97M ﹤0.01% 3023

Other funds holding KAI

David Shaw's KAI Position: Q2 2026 in Review

David Shaw reduced its Kadant (KAI) stake by 51% in Q2 2026, selling an estimated $846K and leaving 2,613 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

David Shaw first reported a position in KAI in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.32M in Q2 2023. 321 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

  • David Shaw held 2,613 shares of Kadant worth $821K as of Q2 2026.
  • David Shaw sold 2,715 Kadant shares in Q2 2026, an estimated $846K.
  • Kadant made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3883 holding.
  • David Shaw first reported a position in Kadant in Q2 2013 and has held it in 50 quarters since.
  • David Shaw's Kadant position peaked at $2.32M in Q2 2023.
  • 321 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.